Disseminated cryptococcosis causes adrenal insufficiency in an immunocompetent individual.

Disseminated cryptococcosis infection occurs mainly in the immunocompromised host. There are only a few reports describing disseminated cryptococcosis in immunocompetent patients. Here, we describe the case of a 46-year-old healthy man who presented with primary adrenal insufficiency with hyponatremia, hyperkalemia and skin pigmentation. Contrast-enhanced adrenal computed tomography (CT) revealed bilaterally enlarged adrenal glands without enhancement. CT-guided percutaneous adrenal gland biopsy showed caseous-like necrosis and embedded cryptococcosis. The serum cryptococcal antigen titer was 1:512. After ten months of fluconazole treatment, the serum cryptococcal antigen titer remained elevated at 1:256 and contrast-enhanced adrenal magnetic resonance imaging revealed continued enlargement of bilateral adrenal glands without enhancement. The patient is currently on a therapeutic regimen of prednisolone, fludrocortisone and fluconazole and is scheduled for regular outpatient follow-up.

[1]  C. Mody,et al.  Cryptococcosis: an emerging respiratory mycosis. , 2009, Clinics in chest medicine.

[2]  A. Casadevall,et al.  The capsule of the fungal pathogen Cryptococcus neoformans. , 2009, Advances in applied microbiology.

[3]  J. Perfect,et al.  Cryptococcosis in solid organ transplant recipients: current state of the science. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  J. Lodge,et al.  Cryptococcus neoformans, a fungus under stress. , 2007, Current opinion in microbiology.

[5]  J. Seckl,et al.  Hyponatraemia for the clinical endocrinologist , 2005, Clinical endocrinology.

[6]  D. Mathai,et al.  Clinical manifestations and management of cryptococcal infection. , 2005, Journal of postgraduate medicine.

[7]  S. Shoham,et al.  Cryptococcus neoformans meningitis at 2 hospitals in Washington, D.C.: adherence of health care providers to published practice guidelines for the management of cryptococcal disease. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  Maria I. New,et al.  Addison’s Disease 2001 , 2001 .

[9]  G. Quindós,et al.  [A new generation of antifungal drugs]. , 2001, Revista iberoamericana de micologia.

[10]  S. Ten,et al.  Clinical review 130: Addison's disease 2001. , 2001, The Journal of clinical endocrinology and metabolism.

[11]  J. Perfect,et al.  Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  H. Tohda,et al.  Disseminated cryptococcosis associated with adrenal masses and insufficiency. , 1998, The American journal of the medical sciences.

[13]  Y. Shishiba,et al.  Disseminated cryptococcosis presenting with adrenal insufficiency and meningitis: resistant to prolonged antifungal therapy but responding to bilateral adrenalectomy. , 1992, Internal medicine.

[14]  J. Shelhamer,et al.  The Causes of Death in Patients with Human Immunodeficiency Virus Infection: A Clinical and Pathologic Study with Emphasis on the Role of Pulmonary Diseases , 1991, Medicine.

[15]  N. Watts,et al.  Disseminated cryptococcosis in an apparently normal host presenting as primary adrenal insufficiency: diagnosis by fine needle aspiration. , 1989, The American journal of medicine.

[16]  H. Taylor,et al.  Adrenal insufficiency due to cryptococcosis. , 1986, JAMA.

[17]  A. Forrestel,et al.  CRYPTOCOCCOSIS , 1982, The Lancet.